You are here

Eli Lilly

These 5 Drugs Could Be Worth $45 Billion -- and They're Not Even on the Market Yet

Motley Fool

Sun, 07/23/17 - 11:47 am

J&J's Invokana continues downward market-share spiral as Lilly, BI's Jardiance advances

Fierce Pharma

Wed, 07/19/17 - 07:47 pm

Boehringer Ingelheim

Eli Lilly buys itself an antibody R&D platform from Tillman Gerngross’s Adimab

Endpoints

Wed, 07/19/17 - 09:28 am

Lilly fends off Cialis generics with new patent settlement

Fierce Pharma

Thu, 07/13/17 - 05:31 pm

erectile dysfunction

5 Pharma & Biotech Stocks That Could Be Big Winners in Q2 Earnings

Yahoo/Zacks.com

Thu, 07/13/17 - 09:49 am

Gilead Sciences

Lilly revs up to challenge Pfizer, Novartis in breast cancer with abemaciclib 'priority' nod

Fierce Pharma

Tue, 07/11/17 - 09:56 am

Why Drugmakers Aren’t Sweating the Next Wave of Patent Losses

Bloomberg

Sat, 07/8/17 - 10:18 am

Eli Lilly Wins Cancer Drug Patent Case at U.K. Supreme Court

Bloomberg

Fri, 07/7/17 - 10:01 am

Teva Pharmaceutical

Eli Lilly pledges up to $52m to Purdue for improving injection tech

Drug Delivery Business News

Thu, 07/6/17 - 02:39 pm

Purdue Univeristy

Lilly’s Olumiant, spurned by FDA, gets nod from NICE

Fierce Pharma

Sat, 07/1/17 - 09:26 am

rheumatoid arthritis

BI, Lilly hit the streets to talk up Jardiance's cardiovascular benefits

Fierce Pharma

Wed, 06/28/17 - 10:13 am

Boehringer Ingelheim

DTC advertising

Little Alder bags positive PhIII migraine data, but giant rivals are racing ahead in a crowded field

Endpoints

Tue, 06/27/17 - 09:38 am

Alder Biopharma

clinical trials

Eli Lilly completes expansion of San Diego biotech center

Fierce Biotech

Fri, 06/23/17 - 09:44 am

For diabetes drugs, lowering blood sugar may no longer be enough to stay competitive

Medical Marketing and Media

Thu, 06/22/17 - 09:32 am

Alzheimer’s Drug Pipeline Analysis: Have We Hit Peak Amyloid?

Xconomy

Wed, 06/21/17 - 09:46 am

Alzheimer's disease

Eli Lilly CEO David Ricks weighs in on drug costs and health reform

CNBC

Sat, 06/17/17 - 07:25 pm

healthcare reform

5 Things You Didn't Know About Eli Lilly and Co

Motley Fool

Thu, 06/15/17 - 09:47 am

Lilly wins FDA nod for Humalog pre-filled Junior KwikPen device

Drug Delivery Business News

Wed, 06/14/17 - 09:05 pm

J&J's Invokana lowers CV risk, but by enough to compete?

BioPharma Dive

Wed, 06/14/17 - 11:37 am

Boehringer Ingelheim

ADA: Merck, Pfizer notch success, but late with SGLT-2 data

BioPharma Dive

Tue, 06/13/17 - 12:15 pm

SGLT2 inhibitor

Boehringer Ingelheim

Pages